Magnetic resonance imaging on disease reclassification among active surveillance candidates with low-risk prostate cancer: a diagnostic meta-analysis.
about
Prostate MRI - an update for the referring urologistDifference of opinion - Active surveillance in intermediate risk prostate cancer: is it safe? Opinion: Yes.Magnetic resonance imaging for prostate cancer before radical and salvage radiotherapy: What radiation oncologists need to know.Confirmatory biopsy of men under active surveillance: extended versus saturation versus multiparametric magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy.ProPSA and the Prostate Health Index as predictive markers for aggressiveness in low-risk prostate cancer-results from an international multicenter study.The performance of PI-RADSv2 and quantitative apparent diffusion coefficient for predicting confirmatory prostate biopsy findings in patients considered for active surveillance of prostate cancer.Value of 3-Tesla multiparametric magnetic resonance imaging and targeted biopsy for improved risk stratification in patients considered for active surveillance.Multiparametric magnetic resonance imaging and active surveillance: How to better select insignificant prostate cancer?Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance Study.Optimization and evaluation of reference region variable flip angle (RR-VFA) B1+ and T1 Mapping in the Prostate at 3T.Inhibition of Gli1-mediated prostate cancer cell proliferation by inhibiting the mTOR/S6K1 signaling pathway.Repeat multiparametric MRI in prostate cancer patients on active surveillance.Active Surveillance Versus Watchful Waiting for Localized Prostate Cancer: A Model to Inform Decisions.Multi-parametric magnetic resonance imaging monitoring patients in active surveillance for prostate cancer: a prospective cohort study.Prostate cancer: in-bore magnetic resonance guided biopsies at active surveillance inclusion improve selection of patients for active treatment.Can MRI/TRUS fusion targeted biopsy replace saturation prostate biopsy in the re-evaluation of men in active surveillance?Indications for and transitioning to secondary treatment while on active surveillance for prostate cancer.Imaging for the selection and monitoring of men on active surveillance for prostate cancer.Entering an era of radiogenomics in prostate cancer risk stratification
P2860
Q26739725-F549A163-5A7A-4A17-AE1B-D74E150F365CQ37037017-88A1A57E-91D6-49D4-95E7-90EBCBDECC03Q38636446-998F629E-8E16-4085-A9BD-1957842B691FQ38781089-BADBBFB6-8895-483D-AE1A-2B087C11C3AEQ38891544-3064D838-5504-4533-9FD5-040B4D158583Q38930394-3AB5B8DA-C4BE-483F-861A-178855B77E52Q39513641-CBD0E4C4-EFD7-46CD-BF9F-952CA7D61754Q39699690-72395F5A-5C47-4F44-A249-F3CCAB191DEEQ45046421-39E16C48-E8EF-40F1-8878-5E1EDE425258Q46818389-78A893D6-9071-4AFA-9947-21DC89A91912Q47283316-9E1699A4-1B47-4A96-9C20-810E42E26239Q48342579-C263D50E-E5CF-4D1D-AA4B-C6D16D8233FCQ48681310-E07DDEC8-A330-480E-A94C-A972CBB60EBDQ50047511-1660AF29-D5C3-43D5-AED7-103EAA7EAC81Q51819245-C45AE1E8-9F5C-497E-92DF-D7AFAAB0CA42Q53233702-EB3B6A05-BF14-4526-82AE-6C94E7B8A01FQ55025747-9C6639FC-3A82-4DA5-BC4E-F92CF384E00EQ55259128-91EF6333-1879-4704-A938-526D92EC67D9Q58562049-D0EFA87A-D77A-417A-9958-72DD3A24D0F4
P2860
Magnetic resonance imaging on disease reclassification among active surveillance candidates with low-risk prostate cancer: a diagnostic meta-analysis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Magnetic resonance imaging on ...... r: a diagnostic meta-analysis.
@en
type
label
Magnetic resonance imaging on ...... r: a diagnostic meta-analysis.
@en
prefLabel
Magnetic resonance imaging on ...... r: a diagnostic meta-analysis.
@en
P2093
P2860
P356
P1476
Magnetic resonance imaging on ...... r: a diagnostic meta-analysis.
@en
P2093
P2860
P2888
P304
P356
10.1038/PCAN.2015.20
P50
P577
2015-05-19T00:00:00Z
P6179
1000895387